Clinical Trial Update: Omacor for Perimenopausal Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Omacor for perimenopausal depression was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)

Snippet

Sponsor: University of Arizona | Conditions: Depression | Phase 2 | Status: WITHDRAWN